Shandong Pharmaceutical Glass Co Ltd (600529) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥41.46 Million ≈ $6.07 Million USD) by net assets (CN¥8.29 Billion ≈ $1.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shandong Pharmaceutical Glass Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Shandong Pharmaceutical Glass Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600529 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Shandong Pharmaceutical Glass Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Pharmaceutical Glass Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GS Engineering & Construction
KO:006360
|
0.011x |
|
Suzhou GYZ Electronic Technology Co. Ltd. A
SHG:688260
|
0.057x |
|
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SHG:603707
|
0.072x |
|
Shenzhen SDG Information Co Ltd
SHE:000070
|
-0.030x |
|
Burkhalter Holding AG
SW:BRKN
|
0.638x |
|
TBO Tek Ltd
NSE:TBOTEK
|
0.021x |
|
Primaris Retail R.E. Invest. Tr. Units
TO:PMZ-UN
|
0.008x |
|
Poly Medicure Limited
NSE:POLYMED
|
0.029x |
Annual Cash Flow Conversion Efficiency for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Shandong Pharmaceutical Glass Co Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
CN¥576.92 Million ≈ $84.42 Million |
0.070x | -52.19% |
| 2024-12-31 | CN¥8.01 Billion ≈ $1.17 Billion |
CN¥1.17 Billion ≈ $170.48 Million |
0.145x | +4.60% |
| 2023-12-31 | CN¥7.53 Billion ≈ $1.10 Billion |
CN¥1.05 Billion ≈ $153.35 Million |
0.139x | +283.58% |
| 2022-12-31 | CN¥6.96 Billion ≈ $1.02 Billion |
CN¥252.44 Million ≈ $36.94 Million |
0.036x | -77.43% |
| 2021-12-31 | CN¥4.67 Billion ≈ $683.41 Million |
CN¥750.44 Million ≈ $109.81 Million |
0.161x | +20.82% |
| 2020-12-31 | CN¥4.26 Billion ≈ $622.77 Million |
CN¥566.01 Million ≈ $82.82 Million |
0.133x | -14.13% |
| 2019-12-31 | CN¥3.87 Billion ≈ $565.98 Million |
CN¥599.05 Million ≈ $87.66 Million |
0.155x | +17.24% |
| 2018-12-31 | CN¥3.53 Billion ≈ $515.92 Million |
CN¥465.77 Million ≈ $68.16 Million |
0.132x | +4.23% |
| 2017-12-31 | CN¥3.25 Billion ≈ $475.62 Million |
CN¥411.96 Million ≈ $60.28 Million |
0.127x | -23.84% |
| 2016-12-31 | CN¥3.04 Billion ≈ $445.37 Million |
CN¥506.53 Million ≈ $74.12 Million |
0.166x | -4.43% |
| 2015-12-31 | CN¥2.24 Billion ≈ $327.41 Million |
CN¥389.63 Million ≈ $57.02 Million |
0.174x | +38.83% |
| 2014-12-31 | CN¥2.13 Billion ≈ $311.04 Million |
CN¥266.63 Million ≈ $39.02 Million |
0.125x | -5.20% |
| 2013-12-31 | CN¥2.03 Billion ≈ $297.05 Million |
CN¥268.60 Million ≈ $39.30 Million |
0.132x | +800.22% |
| 2012-12-31 | CN¥1.94 Billion ≈ $283.93 Million |
CN¥28.52 Million ≈ $4.17 Million |
0.015x | -90.10% |
| 2011-12-31 | CN¥1.85 Billion ≈ $270.68 Million |
CN¥274.63 Million ≈ $40.19 Million |
0.148x | +19.41% |
| 2010-12-31 | CN¥1.75 Billion ≈ $255.40 Million |
CN¥217.01 Million ≈ $31.76 Million |
0.124x | -20.53% |
| 2009-12-31 | CN¥1.59 Billion ≈ $233.14 Million |
CN¥249.27 Million ≈ $36.48 Million |
0.156x | +147.67% |
| 2008-12-31 | CN¥1.45 Billion ≈ $212.56 Million |
CN¥91.76 Million ≈ $13.43 Million |
0.063x | -32.69% |
| 2007-12-31 | CN¥1.31 Billion ≈ $191.22 Million |
CN¥122.63 Million ≈ $17.95 Million |
0.094x | +10.60% |
| 2006-12-31 | CN¥924.74 Million ≈ $135.32 Million |
CN¥78.47 Million ≈ $11.48 Million |
0.085x | +65.83% |
| 2005-12-31 | CN¥861.57 Million ≈ $126.08 Million |
CN¥44.09 Million ≈ $6.45 Million |
0.051x | +1202.83% |
| 2004-12-31 | CN¥797.19 Million ≈ $116.65 Million |
CN¥-3.70 Million ≈ $-541.26K |
-0.005x | -105.67% |
| 2003-12-31 | CN¥725.23 Million ≈ $106.12 Million |
CN¥59.35 Million ≈ $8.68 Million |
0.082x | -51.29% |
| 2002-12-31 | CN¥650.32 Million ≈ $95.16 Million |
CN¥109.26 Million ≈ $15.99 Million |
0.168x | +31.77% |
| 2001-12-31 | CN¥224.34 Million ≈ $32.83 Million |
CN¥28.60 Million ≈ $4.19 Million |
0.128x | -- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more